Compounded semaglutide
Sold by Omzo · every compounded semaglutide record
The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.
What you actually pay
Per month
$179
| Medication · Semaglutide, starting price | $179 |
|---|
Added from the figures recorded below.
Price
| Term | Per month | Charged today |
|---|---|---|
| Semaglutide, starting price “Semaglutide One simple injection per week. Starting at $179” | Per month$179 | Charged today$179 |
We earn nothing from this link. Omzo has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.
History
One reading so far. A price history appears here after the next verification pass.
- September 2, 2026 — Entry added to the register
Sourcing and terms
| States | All 50 states |
|---|---|
| Cancellation | “If a subscription is canceled after a charge has been processed: Cancellation will prevent future charges, but previously processed charges are non-refundable.” |
Not yet checked: pharmacy, prescriber, membership and consult fee.
Recorded from omzo.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.
Notes
- 1. September 2, 2026 — The /weight-loss page is a JavaScript-rendered shell with no visible pricing text; the only GLP-1 prices found were the homepage's 'Starting at $179' (semaglutide) and 'Starting at $279' (tirzepatide) tiles, with no unit stated for the figure (assumed monthly, the site's evident convention). Omzo's fee statement says medication cost is bundled into the fees it collects ('Medication costs are included in the fees collected by Omzo'), consistent with these being real program prices rather than an excluded-medication membership. The state-coverage sentence is a stronger, unambiguous '50 states' claim than a vague 'nationwide' phrase, so it was recorded as all-50 rather than not-found.
Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.